What is the current Global Phenylketonuria Treatment Market size?

The Global Phenylketonuria Treatment Market is projected to register a CAGR of 11% during the forecast period (2024-2029) Read More

Who are the key players in Global Phenylketonuria Treatment Market?

BioMarin Pharmaceuticals, SOM Innovation Biotech SL , Homology Medicines Inc. , Censa Pharmaceuticals (PTC Therapeutics) and Codexis Inc. are the major companies operating in the Global Phenylketonuria Treatment Market. Read More

Which is the fastest growing region in Global Phenylketonuria Treatment Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Phenylketonuria Treatment Market?

In 2024, the North America accounts for the largest market share in Global Phenylketonuria Treatment Market. Read More

What years does this Global Phenylketonuria Treatment Market cover?

The report covers the Global Phenylketonuria Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Phenylketonuria Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Phenylketonuria Treatment Market Share

Statistics for the 2023 & 2024 Global Phenylketonuria Treatment market share, created by Mordor Intelligence™ Industry Reports. Global Phenylketonuria Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Phenylketonuria Treatment Industry

The phenylketonuria treatment market is consolidated and consists of a few major players. Some of the companies currently dominating the market are BioMarin Pharmaceuticals Inc., Censa Pharmaceutical, Synlogic Inc., Erytech Pharma SA, Codexis Inc., SOM Innovation Biotech SL, Homology Medicines Inc., and Ultragenyx (Dimension Therapeutics).